UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-QSB

                   Quarterly Report Under Section 13 or 15(d)
                     of the Securities Exchange Act of 1934.

                      For the quarter ended March 31, 2004
                         Commission file number 000-31735

                            NANOSIGNAL CORPORATION, INC.
                (Name of Small Business Issuer in its charter)


        Nevada                                          88-0231200
 (State or other jurisdiction of                      (IRS Employer
 incorporation or organization)                      Identification Number)

                            5440 W Sahara Ave, Suite 206
                       (Address of principal executive offices)

                              Las Vegas, NV  89146
                            (City, State and Zip Code)

                                    (702) 227-5111
                   Company' telephone number, including area code



      Securities registered pursuant to Section 12(b) of the Act: None.

                Name of each exchange on which registered: None.

   Securities registered pursuant to Section 12(g) of the Act: Common Stock

Check whether the Issuer (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or
such shorter period of that the Registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past
90 days.    Yes    X No

The number of shares outstanding of the Company's $.001 Par Value Common
Stock,as of March 31, 2004 were 168,707,788.

The aggregate number of shares of the voting stock held by non-affiliates on
December 31, 2003 was 37,146,745. The market value of these shares, computed
by reference to the market closing price on March 31, 2004 was $3,350,354.
For the purposes of the foregoing calculation only, all directors and
executive officers of the registrant have been deemed affiliates.


<PAGE>



                                   INDEX
                                                                   Page No.

PART I - MANAGEMENT DISCUSSION AND ANALYSIS

   Item 1.   Financial Statements

     Balance Sheet as of March 31, 2004                                 3

     Statement of Expenses for three Months
       ended March 31, 2004 and 2003                                    4

     Statement of Cash Flows for the Three Months ended
       March 31, 2004 and 2003                                          5

     Notes to Financial Statements                                      6

   Item 2.  Business                                                 7-10


PART II - OTHER INFORMATION

   Item 1.   Legal Proceedings                                         10

   Item 2.   Changes in Securities                                  10-12

   Item 3.   Defaults upon Senior Securities                           12

   Item 4.   Submission of Matter to a Vote of Security Holders        12

   Item 5.   Other Information                                         13

   Item 6.   Exhibits and Reports on Form 8-K                          13

SIGNATURES                                                             13

                                   Page Two
<PAGE>

PART I MANAGEMENT DISCUSSIOHN AND ANALYSIS

Item 1  Financial Statements

                             NANOSIGNAL CORPORATION, INC.
                                  BALA NCE SHEET
                                  March 31, 2004
                                    (Unaudited)


<TABLE>
<CAPTION>
                                        ASSETS
<S>                                                              <C>
Current assets
  Cash                                                           $   14,994
                                                                 ----------
    Total current assets                                             14,994

Property and equipment, net                                          62,641
Paintings                                                            10,000


                                                                 ----------
                                                                 $   87,635
                                                                 ----------
                                                                 ----------


                         LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:

  Accounts payable                                               $  115,320
  Accrued expenses                                                  138,292
  Lease payable                                                      38,650
  Accrued interest payable                                          997,509
  Notes payable                                                     615,339
  Notes payable - shareholders                                    2,078,415
  Deposits                                                           40,000
                                                                 ----------
    Total current liabilities                                     4,023,525
                                                                 ----------


STOCKHOLDERS' DEFICIT:

  Superpreferred common stock, $.001 par value,
   50,000,000 shares authorized,
   20,000,000 shares issued    and outstanding                       20,000
  Common stock, $.001 par value, 500,000,000
   shares authorized, 168,707,788 shares issued
   and outstanding                                                  167,797
  Additional paid in capital                                     28,815,100
  Accumulated deficit                                           (28,815,100)
                                                                 ----------
                                                                 (3,935,890)
                                                                 ----------
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                          87,635
                                                                 ----------
                                                                 ----------
</TABLE>
               See accompanying notes to financial statements.

                                   Page Three

<PAGE>

                             NANOSIGNAL CORPORATION, INC.
                                STATEMENTS OF EXPENSES
                 For three Months Ended March 31, 2004 and 2003
                                   (Unaudited)

<TABLE>
<CAPTION>
<S>                                         <C>                <C>
                                            2004               2003
                                            -------------      -------------
Operating Expenses:

  General, selling and administrative       $  1,412,241       $     23,442

  Consulting                                   8,683,293                  -
                                            -------------      -------------

Loss from operations                         (10,095,534)           (23,442)

Interest expense                                  62,106             37,671
                                            -------------      -------------

Net loss                                    $(10,157,640)      $    (61,113)
                                            -------------      -------------
                                            -------------      -------------


Net loss per share:
  Net loss basic and diluted                $      (0.07)      $      (0.00)

Weighted average shares outstanding:

  Basic and diluted                          143,856,971         24,114,627
                                            -------------      -------------
                                            -------------      -------------

</TABLE>
               See accompanying notes to financial statements.

                                   Page Four
<PAGE>

                           NANOSIGNAL CORPORATION, INC.
                             STATEMENTS OF CASH FLOWS
               For three Months Ended March 31, 2004 and 2003
                                 (Unaudited)


<TABLE>
<CAPTION>

                                           2004              2003
<S>                                       <C>                <C>
                                          -------------      -------------
CASH FLOWS FROM OPERATING ACTIVITIES

Net loss                                  $ (10,157,640)     $     (61,113)
Adjustments to reconcile net loss to
cash used by   operating activities:
  Common stock for services                   9,949,588             16,000
  Depreciation                                    2,873                  -
Net change in:
  Accounts payable                              (22,421)             1,854
  Accrued interest payable                       62,106             37,671
                                          -------------      -------------

CASH FLOWS USED IN OPERATING ACTIVITIES        (165,494)            (5,588)
                                          -------------      -------------

CASH FLOWS FROM INVESTING ACTIVITES
  Purchase of property and equipment           (44,320)                  -
  Purchase of paintings                        (10,000                   -

                                          -------------      -------------
CASH FLOWS FROM INVESTING ACTIVITIES           (54,320)                  -
                                          -------------      -------------

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable                     188,420              5,900
                                          -------------      -------------

NET DECREASE IN CASH                            (31 394)               312
Cash, beg. of period                             46,388              1,967
                                          -------------      -------------
Cash, end of period                       $      14,994      $       2,279
                                          -------------      -------------
                                          -------------      -------------

SUPPLEMENTAL CASH FLOW INFORMATION
  Interest paid                           $           -      $           -
  Income taxes paid                       $           -      $           -

NON-CASH TRANSACTIONS:
  Issuance of common stock for assets     $     152,256


</TABLE>
               See accompanying notes to financial statements.

                                   Page Five
<PAGE>

                      NANOSIGNAL CORPORATION, INC.
                     NOTES TO FINANCIAL STATEMENTS
                             (Unaudited)


NOTE 1  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The accompanying unaudited interim financial statements of Nanosignal
Corporation have been prepared in accordance with accounting principles
generally accepted in the United States of America and the rules of the
Securities and Exchange Commission ("SEC"), and should be read in conjunction
with the audited financial statements and notes thereto contained in the
Company's registration statement filed with the SEC on Form 10-KSB.  In the
opinion of management, all adjustments, consisting of normal recurring
adjustments, necessary for a fair presentation of financial position and the
results of operations for the interim periods presented have been reflected
herein.  The results of operations for interim periods are not necessarily
indicative of the results to be expected for the full year.  Notes to the
financial statements which would substantially duplicate the disclosure
contained in the audited financial statements for the most recent fiscal year
end December 31, 2003 as reported in Form 10-KSB, have been omitted.


NOTE 2  COMMON STOCK

In March 2004 NanaSignal changed the authorized shares of Common Stock from
300,000,000 to 500,000,000 and changed the Superpreferred Common Stock from
20,000,000 to 50,000,000.  The Superpreferred Common Stock has voting rights
of ten votes per each one share of Superpreferred Common Stock.

During the three months ending March 31, 2004 NanoSignal issued 56,384,074
shares of common stock for services valued at $10,081,844.

On January 12, 2004 a related party to the company returned 10,000,000 shares
of common stock for 20,000,000 shares of superpreferred common stock.  This
issuance gave this shareholder a majority voting interest in the company.
The stock issued was valued at $1,500,000 which was the fair market value of
the additional 10,000,000 shares issued.  In the same transaction the
shareholder relieved $152,256 of debt that NanoSignal owed.


NOTE 3  COMMITMENTS

NanoSignal entered into a lease in October 2002 for office space located in
Pittsburgh, Pennsylvania on a three year lease term through September 2005.
This lease was cancelled in April 2004 and no future payments were necessary.
The monthly rental payment was $1,854 per month.

In February 2004 NanoSignal signed a sublease agreement with a shareholder
for office space in Las Vegas, Nevada.  NanoSignal signed a three year
contact beginning February 1, 2004 for $4,500 per month.

Employment Agreement

Effective February 2, 2004 NanoSignal entered into an employment agreement
with its Chief Executive Officer.  The one year agreement provides for an
annual salary of $182,500 for each year, plus incentives and certain employee
benefits, as defined by the agreement.  The agreement also provides for
5,000,000 shares of common stock.


NOTE 4  SUBSEQUENT EVENT

In April 2004, NanoSignal entered into a settlement agreement with a former
officer of the Company and agreed to issue 28,000,000 shares of common stock
and pay a commission fee of 10% for his referrals.

Subsequent to March 31, 2004 NanoSignal issued 35,050,000 shares of common
stock for services.  The shares will be valued using the fair market value of
the stock on the date of issuance.

On June 1, 2004 NanoSignal issued 30,000,000 shares of superpreferred common
stock for services.   The shares will be valued using the fair market value
of the stock on the date of issuance.


                                   Page Six

<PAGE>

ITEM 2.  BUSINESS

A) General

MicroSignal Corporation (the "Company") was incorporated on August 21, 1987 as
"Ragen Corporation" under the laws of the State of Nevada. On October 21,
1999, the Company entered into a reverse merger pursuant to Rule
368(a)(1)(B)if the Internal Revenue Code of 1986 as amended. Pursuant to this
reverse merger, the Company acquired 100% of the common stock of Pro Glass
Technologies, Inc., a Canadian corporation with three wholly owned
subsidiaries in exchange for the issuance of 17,714,000 shares of the
Company's common stock. The Company changed its name to "Pro Glass
Technologies, Inc." and increased the number of authorized common shares to
50,000,000 at that time. Pro Glass Technologies, Inc. is the predecessor due
to the reverse merger and Ragen was the legal survivor. Pro Glass
Technologies, Inc. was a holding company.

Upon completion of the merger, the Company began engaging in the auto glass
repair and replacement business under "Windshield Superstores, Ltd." in
Calgary, Alberta. Fran Aiello became the President and CEO of the Company at
that time.

On September 10, 2002, the Company entered into an Agreement and Plan of
reorganization with MicroSignal Corporation, a Pennsylvania corporation, and
exchanged 100% of the MicroSignal common stock in exchange for the issuance
of 17,051,344 shares of the Company's common stock, or 94% of the Company.
At that time, the Company changed its name to "MicroSignal Corporation".  At
the same time, the Company sold its auto glass repair and replacement
business to its former president, Frank Aiello, in change for the return of
150,000 shares of the Company's common stock owned by him. Mr. Aiello assumed
responsibility for all the debts and liabilities of the auto glass repair and
replacement business. For accounting purposes, this transaction was treated
as an acquisition of Pro Glass and a recapitalization of MicroSignal,
MicroSignal is the accounting acquirer and the results of its operations
carry over. Accordingly, the operations of the Company while Pro Glass are
not carried over and are adjusted to $0. As part of this transaction, the
Company's fiscal year end changed from September 30 to December 31.

The Company has developed a product designed to improve the quality and
efficiency of magnetic resonance imaging ("MRI") systems. The product
consists of a combination of hardware and software compatible with all MR
machines, designed to improve the image quality as well as the display of the
final MRI exam. At the core of the system is a totally novel method of
reconstructing the MR information obtained by the machine (the raw data),
developed by Dr. Jeffery Taft. The Company's product uses a unique algorithm,
exchange analytic computation technique (EXACT), which decouples the size of
the raw data from the image matrix size and overcomes a lot of the inherent
limitations of the Fourier transformations.  The technology allows tremendous
flexibility once the MRI data has been acquired; it is possible using
SLICES(TM) to obtain sharply magnified images, up to ten times the original
magnification, without creating pixel artifacts inherent to the optical zoom
provided by all manufacturers. The major benefits of MSC's SLICES technology
are:

Increased information extraction
Helps with the elimination of some artifacts
Improves the radiologist's productivity
Reduces patient re-scan and call back
Reduces patient scan time Reduces film costs

The Company intends to proceed with marketing and sales of the Company's
proprietary product.

                                   Page Seven

<PAGE>

Significant opportunities exist for follow-on product both in MRI and in
other computed medical imaging applications such as CAT scan and
nuclear medicine. Exciting opportunities exist to apply new proprietary
MicroSignal Corporation technology to stroke prediction, breast cancer
detection and cardiac evaluation, thus expanding MRI into use for the top
three disease conditions in the U.S. Sales opportunities for these
additional products are in the billions of dollars.

Additional opportunities exist to make use of the Internet to perform high-
end teleradiology and Picture Archiving and Control. MicroSignal
Corporation can become the preferred channel not only for computing and
displaying medical images, but also for transporting them. The transport, if
done properly, can result in an ongoing revenue stream valued in the hundreds
of millions of dollars per year within five years.  There can be no
assurances that the Company will see these results. Future revenues are
dependent upon the Company being able to secure outside financing and raising
additional capital to enable it to commence operations in a meaningful
manner, neither of which the Company has commitments to receive. Until such
time as the Company is able to secure additional financing through loans or
capital raising, the Company's efforts to commence revenue producing
operations will have to be scaled back.

The Company formally changed its name to NanoSignal, Inc in November 2003.
Henceforth, all references to the Company will be with its current name.  The
Company has changed its name effective immediately to "NanoSignal Corporation,
Inc." and has applied for a new trading symbol with the NASD. The Company's
new CUSIP number is 63008S 10 8.

On Jan. 21, 2004--Micro Bio-Medical Waste Systems, Inc. announced the
appointments of Dr. Rupert A.L. Perrin and Dr. Lawrence Madoff to its Board
of Directors. Also appointed to the Board of Directors is the company's
current CEO Mr. Scott A. Ervin. Scott A. Ervin, President and CEO, stated,
"We are honored to have such high esteemed individuals join our Board of
Directors to assist us in developing an exciting and viable business
venture." Dr. Rupert A.L. Perrin will also assume the key role as the
companies distinguished Chairman of the Board.

On February 2, 2004, the Hon. Judge Arthur J. Schwab in Case No. 03-1589
(U.S. District Ct. W. PA) granted NanoSignal's motion to dismiss cross claims
of Mathew McConaghy. The court held that the "first-filed rule" required that
a Nevada lawsuit filed against Mr. McConaghy by NanoSignal in August 2003 is
where Mr. McConaghy's claims must be heard. Regarding George Park's
litigation, a notice of appeal has been filed in Case No. 03-1589. No appeal
bond or stay of execution has been applied for by George Parks on behalf of
the losing parties. NanoSignal has issued interrogatories to Mr. Parks in aid
of execution of the judgment entered in its favor and it will take all steps
necessary to protect its intellectual property, including SLICES(TM)
Technology, from infringement.

On Feb. 3, 2004--NanoSignal Corporation announced the appointment and
acceptance of Mr. Scott A. Ervin to the Board of Directors. Currently
Mr. Ervin is President and CEO of Micro Bio-Medical Waste Systems, Inc.
(MBWS), a role in which he will continue to perform. At NanoSignal, Mr. Ervin
will provide seasoned financial management experience. Mr. Ervin has over 30
years of experience in management, marketing and financial consulting.
Mr. Ervin has managed a number of real estate projects on the East Coast and
London where he represented property owners. During this period, Mr. Ervin
worked as Executive Vice President of the First Boston Corporation; Vice
President and Rental Manager of Rockefeller Center Inc.; Director of Leasing
and Limited Partner for Fisher Brothers; and Co-Managing Partner for Ashley
Properties, Ltd.

                                   Page Eight

<PAGE>

FINANCIAL CONDITION AND CHANGES IN FINANCIAL CONDITION

OVERALL OPERATING RESULTS:

The Company plans to seek financing and capital to allow it to exploit this
technology as well as to enhance and improve on this technology. During 2004,
the Company intends to seek the necessary financing to allow it to implement
its business plan and to commence operations in a meaningful way.

We have had no revenues for the three months ended March 31, 2004 and 2003,
respectively.

Our operating expenses for the quarter ended March 31, 2004 were $10,157,640
and were primarily incurred for consultants, rent and other services rendered
in connection with our financial reporting obligations with the Securities
and Exchange Commission as well as stock transfer agent fees. Operating
expenses for the prior year quarter ended March 31, 2003 totaled $61,113 for
general expenses.


LIQUIDITY AND CAPITAL RESOURCES:
     The Company has approximately $14,994 in current assets compared to
     current assets of approximately $2,279 for the year ended December 31,
     2003. The Company's current liabilities for the period ended March 31,
     2004 are approximately $4,023,525 compared to current liabilities of
     approximately $3,007,000 for the previous first quarter reporting period
     ended March 31, 2003. Total assets were approximately $87,635 for the
     period ended March 31, 2004 composed of the Company's prepaid rent,
     equipment and paintings.

At March 31, 2004, the Company had negative working capital of approximately
$3,935,890 which consisted of current assets of approximately $87,635 and
current liabilities of approximately $4,023,525. At March 31, 2003, the
Company had negative working capital of approximately $3,005,000 which
consisted of current assets of approximately $2, 279 assets and current
liabilities of approximately $3,007,000. The current liabilities of the
Company at March 31, 2004 are composed primarily of trade payables of
$115,320, lease payables of 38,650, Notes payable to Shareholders of
$2,078,415, accrued interest payable of  $138,292, other notes payable of
$615,339, deposits of $40,000 and accrued interest of $ 997,509.

The Company will attempt to carry out its business plan as discussed above.
The Company cannot predict to what extent its lack of liquidity and capital
resources will hinder its business plan prior to commencement of its proposed
operations.


NEED FOR ADDITIONAL FINANCING

The Company's existing capital is not sufficient to meet the Company's
cash needs, including the costs of compliance with the continuing reporting
requirements of the Securities Exchange Act of 1934, as amended.

No commitments to provide additional funds have been made by management or
other stockholders. Accordingly, there can be no assurance that any funds
will be available to the Company to allow it to cover its expenses.

The Company might seek to compensate providers of services by issuances of
stock in lieu of cash.

Employees

As of March 31, 2004, the Company had three employees.

                                   Page Nine

<PAGE>

DESCRIPTION OF PROPERTIES

The Company presently subleases office space on a one-year lease, which ends
in March 2005. The monthly lease payment is $4,500. The Company anticipates
that this space is sufficient for the near future.

NEW ACCOUNTING PRONOUNCEMENTS

In April 2002, the FASB approved for issuance Statements of Financial
Accounting Standards No. 145, "Rescission of FASB Statements No. 4, 44 and 64,
Amendment of SFAS 13, and Technical Corrections" ("SFAS 145"). SFAS 145
rescinds previous accounting guidance, which required all gains and losses
from extinguishment of debt be classified as an extraordinary item. Under SFAS
145 classification of debt extinguishment depends on the facts and
circumstances of the transaction. SFAS 145 is effective for fiscal years
beginning after May 15, 2002 and is not expected to have a material effect
on the Company's financial position or results of its operations.

In July 2002, the FASB issued Statements of Financial Accounting Standards
No. 146, "Accounting for Costs Associated with Exit or Disposal Activities"
(SFAS 146). SFAS 146 requires companies to recognize costs associated with
exit or disposal activities when they are incurred rather than at the date
of a commitment to an exit or disposal plan. Examples of costs covered by
SFAS 146 include lease termination costs and certain employee severance costs
that are associated with a restructuring, discontinued operation, plant
closing, or other exit or disposal activity. SFAS 146 is to be applied
prospectively to exit or disposal activities initiated after December 31,
2002. The adoption of SFAS 146 is not expected to have a material effect on
the Company's financial position or results of its operations.

In December 2002, the FASB issued Statements of Financial Accounting Standards
No. 148 "Accounting for Stock-Based Compensation--Transition and Disclosure"
an amendment of FASB Statement No. 123, This Statement amends FASB Statement
No. 123, Accounting for Stock-Based Compensation, to provide alternative
methods of transition for a voluntary change to the fair value based method
of accounting for stock-based employee compensation. In addition, this
Statement amends the disclosure requirements of Statement 123 to require
prominent disclosures in both annual and interim financial statements about
the method of accounting for stock-based employee compensation and the effect
of the method used on reported results. The adoption of SFAS 148 is not
expected to have a material effect on the Company's financial position or
results of its operations.


Inflation

The Company's results of operations have not been affected by inflation and
management does not expect inflation to have a significant effect on its
operations in the future.


PART II OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS
None

ITEM 2. CHANGES IN SECURITIES

On January 6, 2004 the Company issued to Marcus Lune 2,500,000 shares at .15
per share.

On January 6, 2004 the Company issued to RonSanford 2,500,000 shares at .15
per share.

On January 6, 2004 the Company issued to Jason Landess 1,000,000 shares at
..15 per share which were refused.

                                     Page Ten

<PAGE>

On January 6, 2004 the Company issued to David Disner 1,500,000 shares at
..15 per share.

On January 6, 2004 the Company issued to Tony Marcus 1,500,000 shares at .15
per share.

On January 6, 2004 the Company issued to Harold Gewerter 2,500,000 shares at
..20 per share.

On February 17, 2004 the Company issued to Juan Ferreira 300,000 shares at
..22 per share.

On February 17, 2004 the Company issued to KC Quintana 4,000,000 shares at
..22 per share.

On February 17, 2004 the Company issued to Steve Cummins 3,500,000 shares at
..22 per share.

On February 17, 2004 the Company issued to Charles Lindsey 1,342,956 shares
at .22 per share which were refused.

On February 17, 2004 the Company issued to Andrea Lindsey 400,000 shares at
..22 per share.

On February 17, 2004 the Company issued to Mike Rini 1,430,000 shares at .22
per share.

On February 17, 2004 the Company issued to Jin Stock 350,000 shares at .22 per
share.

On February 17, 2004 the Company issued to Annalie Galicia 378,378 shares at
..22 per share.

On February 17, 2004 the Company issued to Stacy McBee 3,000,000 shares at
..22 per share.

On February 17, 2004 the Company issued to Dr. Lawrence Madoff  400,000 shares
at .22 per share.

On February 17, 2004 the Company issued to Dr. Rupert Perin 400,000 shares at
..22 per share.

On March 18, 2004 the Company issued to John Dolkart 4,000,000 shares at .103
per share.

On March 18, 2004 the Company issued to John McBride 5,000,000 shares at .103
per share.

On March 18, 2004 the Company issued to Antonio Macaraeg 5,000,000 shares at
..103 per share.

On March 18, 2004 the Company issued to Steve Cummins 10,000,000 shares at
..103 per share.

On March 18, 2004 the Company issued to Thomas Martinez 4,000,000 shares at
..103 per share.

On March 18, 2004 the Company issued to Juan Ferreira 600,000 shares at .103
per share.

On March 18, 2004 the Company issued to Marcus Luna 3,000,000 shares at .103
per share.

The total shares issued equal 56,384,074.

                                Page Eleven

<PAGE>

RECENT SALES OF UNREGISTERED SECURITIES

On January 12, 2004 the Company issued to Gary Walters 20,000,000 shares of
the Companies Super Preferred Stock for 10,000,000 shares of common stock and
the cancellation of $152,256 in debt.

On January 29, 2004 the Company issued to Dr. Jeffrey Taft 10,000,000 shares
at .14 per share.

On January 29, 2004 the Company issued to Ali Norshivana 2,500,000 shares at
..14 per share.

On March 4, 2004 the Company issued to Nasser Afzaly 15,500,000 shares at .15
per share.

On March 4, 2004 the Company issued to Stacy McBee 10,000,000 shares at .15
per share.

On March 4, 2004 the Company issued to KC Quintana 10,000,000 shares at .15
per share.

On March 4, 2004 the Company issued to Gary Walters 12,750,000 shares at .15
per share.

On March 4, 2004 the Company issued to 20/20 Investment Group 10,000,000
shares at .15 per share.

On March 4, 2004 the Company issued to Pat Amendolia 10,000,000 shares at .15
per share.

On March 4, 2004 the Company issued to Dr. Lawrence Madoff 1,250,000 shares
at .15 per share.

On March 4, 2004 the Company issued to Dr. Rupert Perin 5,000,000 shares at
..15 per share.

On March 4, 2004 the Company issued to Scott Ervin 5,000,000 shares at .15
per share.

On March 15, 2004 the Company issued to Stephen Cummings 10,000,000 shares at
..12 per share.

On March 24, 2004 the Company issued to NanoSignal employee stock program
5,000,000 shares at .12 per share.

On March 24, 2004 the Company issued to Micro Bio-Medical Technologies
1,959,048 shares at .12 per share.

On April 4, 2004 the Company issued to John Dolkart 3,000,000 shares at .22
per share.

     This represented 111,459, 048 shares of restricted stock.  In a
     subsequent event, the Board of Directs cancelled all of these shares at
     its May 17, 2004 meeting.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.


ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

In January 2004, the Company voted to increase its authorized shares of
common stock from 300,000,000 shares to 500,000,000 shares and increase its
super common stock from 20 million to 50 million.

No subsequent issues have been submitted to the shareholders.

                                Page Twelve

<PAGE>

ITEM 5. OTHER INFORMATION

None.


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

a. Exhibits

Exhibit Number Name of Exhibit

None

b. Reports on Form 8-K

On January 6, 2004, NanoSignal, Inc. filed a report on Form 8-K, which
reported under its submission of its annual report.

Signatures
In accordance with Section 13 or 15(d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

(Registrant) NANOSIGNAL CORPORATION, INC.

By  /s/  Mr. Scott Ervin
    ------------------------------
    Mr. Scott Ervin, CEO


Date July 23, 2004